Aquestive Therapeutics, Inc. (AQST) Ownership

$3.72

$0.04 (1.09%)
Last update: 01:00 PM EST
Day's range
$3.61
Day's range
$3.76

Aquestive Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BRATTON CAPITAL MANAGEMENT, L.P. 05/15/2025 9.81 M $28.45 M   0.00% 10.27%
BLACKROCK, INC. 05/02/2025 5.94 M $17.21 M   -1.05% 6.22%
VANGUARD GROUP INC 05/09/2025 4.07 M $11.81 M   -6.29% 4.27%
PERCEPTIVE ADVISORS LLC 05/15/2025 3.73 M $10.81 M   100.00% 3.90%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 1.70 M $4.93 M   2.79% 1.78%
MORGAN STANLEY 05/15/2025 1.53 M $4.43 M   107.26% 1.60%
STATE STREET CORP 05/15/2025 1.52 M $4.42 M   1.25% 1.59%
PALE FIRE CAPITAL SE 05/14/2025 1.34 M $3.87 M   154.05% 1.40%
BANK OF AMERICA CORP /DE/ 05/15/2025 1.33 M $3.86 M   92.75% 1.39%
JANNEY MONTGOMERY SCOTT LLC 04/17/2025 1.06 M $3.07 M   7.65% 1.11%
BLUE OWL CAPITAL HOLDINGS LP 05/15/2025 920.00 K $2.67 M   2.22% 0.96%
GOLDMAN SACHS GROUP INC 06/27/2025 818.85 K $2.37 M   -6.58% 0.86%
NORTHERN TRUST CORP 05/13/2025 587.83 K $1.70 M   -2.00% 0.62%
TWO SIGMA ADVISERS, LP 05/15/2025 576.40 K $1.67 M   3,502.50% 0.60%
HARVEY CAPITAL MANAGEMENT INC 04/30/2025 499.57 K $1.45 M   86.83% 0.52%
CITADEL ADVISORS LLC 05/15/2025 459.55 K $1.33 M   20.40% 0.48%
BRACEBRIDGE CAPITAL, LLC 05/15/2025 459.22 K $1.33 M   0.00% 0.48%
WOODLINE PARTNERS LP 05/15/2025 407.66 K $1.18 M   -0.40% 0.43%
SIO CAPITAL MANAGEMENT, LLC 05/15/2025 391.63 K $1.14 M   100.00% 0.41%
STIFEL FINANCIAL CORP 05/14/2025 375.13 K $1.09 M   -5.88% 0.39%
TWO SIGMA INVESTMENTS, LP 05/15/2025 372.06 K $1.08 M   111.46% 0.39%
UBS GROUP AG 05/13/2025 314.33 K $911.55 K   -25.26% 0.33%
05/16/2025 300.00 K $870.00 K   38.75% 0.31%
JPMORGAN CHASE & CO 05/12/2025 298.02 K $864.25 K   294.72% 0.31%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 285.64 K $828.36 K   47.33% 0.30%
MILLENNIUM MANAGEMENT LLC 05/15/2025 258.22 K $748.83 K   196.03% 0.27%
LATASH INVESTMENTS, LLC 05/13/2025 243.13 K $705.09 K   0.00% 0.25%
05/12/2025 236.47 K $685.77 K   100.00% 0.25%
CAHILL WEALTH MANAGEMENT, LLC 05/12/2025 218.38 K $633.31 K   52.66% 0.23%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 210.70 K $611.03 K   0.01% 0.22%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 205.54 K $596.08 K   14.44% 0.22%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2025 200.00 K $3.04 M   25.00% 0.21%
ENTRYPOINT CAPITAL, LLC 05/14/2025 192.76 K $558.99 K   41.94% 0.20%
EXODUSPOINT CAPITAL MANAGEMENT, LP 05/14/2025 189.18 K $549.00 K   160.91% 0.20%
D. E. SHAW & CO., INC. 05/15/2025 179.04 K $519.20 K   41.57% 0.19%
ADVISOR GROUP HOLDINGS, INC. 05/12/2025 176.26 K $511.15 K   8.50% 0.18%
BANK OF NEW YORK MELLON CORP 04/29/2025 168.89 K $489.77 K   -1.63% 0.18%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2025 167.70 K $486.33 K   100.00% 0.18%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2025 142.00 K $411.80 K   11.81% 0.15%
CITADEL ADVISORS LLC 05/15/2025 136.60 K $396.14 K   108.55% 0.14%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 129.02 K $374.16 K   12.20% 0.14%
RUSSELL INVESTMENTS GROUP, LTD. 05/13/2025 125.50 K $363.94 K   15.65% 0.13%
HIGHTOWER ADVISORS, LLC 05/13/2025 108.66 K $315.12 K   36.45% 0.11%
RHUMBLINE ADVISERS 05/29/2025 104.36 K $302.65 K   -2.43% 0.11%
05/07/2025 91.54 K $265.47 K   100.00% 0.10%
PENN CAPITAL MANAGEMENT COMPANY, LLC 05/14/2025 86.62 K $251.19 K   100.00% 0.09%
CREATIVE PLANNING 05/15/2025 85.62 K $248.30 K   13.62% 0.09%
BARCLAYS PLC 05/15/2025 82.96 K $241.00 K   -30.12% 0.09%
XTX TOPCO LTD 05/08/2025 78.52 K $227.71 K   100.00% 0.08%
AQUATIC CAPITAL MANAGEMENT LLC 05/15/2025 64.91 K $188.24 K   3.67% 0.07%

Aquestive Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 151 institutional investors and hedge funds held shares of Aquestive Therapeutics, Inc.. The most heavily invested institutionals were:

Bratton Capital Management, L.P.: 9.81 M

BlackRock, Inc.: 5.94 M

VANGUARD GROUP INC: 4.07 M

PERCEPTIVE ADVISORS LLC: 3.73 M

GEODE CAPITAL MANAGEMENT, LLC: 1.7 M

MORGAN STANLEY: 1.53 M

46.34% of Aquestive Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 50.20 M shares in the last 24 months. This purchase volume represents approximately $186.74 M in transactions.